The historical rank and industry rank for Allarity Therapeutics's Price-to-Tangible-Book or its related term are showing as below:
During the past 5 years, Allarity Therapeutics's highest Price to Tangible Book Ratio was 17.37. The lowest was 17.37. And the median was 17.37.
ALLR's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.77 * Ranked among companies with meaningful Price-to-Tangible-Book only.
Allarity Therapeutics Price-to-Tangible-Book Historical Data
The historical data trend for Allarity Therapeutics's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Allarity Therapeutics's Price-to-Tangible-Book
For the Biotechnology subindustry, Allarity Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allarity Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Allarity Therapeutics's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Allarity Therapeutics's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Allarity Therapeutics Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Allarity Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Allarity Therapeutics (Allarity Therapeutics) Business Description
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALLR has been successfully added to your 